{"entity":{"id":"navari-surgical","kind":"company","name":"Navari Surgical","aka":["Navari Surgical AB","Navari"],"tldr":"Navari Surgical makes augmented reality software that overlays a view of structures inside an organ onto the camera image during keyhole or robotic cancer surgery. Its first product is for liver tumour operations and is being tested in a first feasibility study in patients.","summary":"Navari Surgical AB, at Lennart Torstenssonsgatan 8, Gothenburg, Sweden, began as a research collaboration between Chalmers University of Technology and Sahlgrenska University Hospital and was developed further through Chalmers School of Entrepreneurship, with mathematicians Klas Modin and Torbjörn Lundh. It makes a manufacturer-agnostic, software-based intraoperative augmented reality tool for minimally invasive surgery: a plug-and-play box that adds an AR layer to the existing surgical video feed and a tablet interface for the surgeon, with a single-use device covered by patents filed in 2022, 2024 and 2025. The first commercial product is aimed at liver cancer surgery; a feasibility and safety study of AR in liver tumour surgery is registered. The company reported proof of concept in a preclinical in vivo study in September 2023. Its first registered cancer trial, NCT07630610, was posted on ClinicalTrials.gov in June 2026. It closed a pre-seed investment of SEK 7.5 million in October 2022 and was granted Vinnova funding under the call Acceleration of deeptech companies in March 2025; it also states it is funded by the European Union.","asOf":"2026-10-29","links":[{"label":"Official website","url":"https://navarisurgical.com/"},{"label":"About Navari, including history and pre-seed round","url":"https://navarisurgical.com/about/"},{"label":"ClinicalTrials.gov: feasibility and safety of augmented reality in liver tumour surgery (NCT07630610)","url":"https://clinicaltrials.gov/study/NCT07630610"}],"tags":[],"related":[],"cancers":[],"sections":["surgery","devices"],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Founding year not stated on the company website."," The corpus has no technology record for surgical augmented reality, so none is linked.","The company homepage carried unrelated injected Polish-language online casino text at the time of reading, which suggests the site has been compromised; the about, solution and news pages were read separately.","Registry trial record not read in full; the description comes from its title and listed condition (liver neoplasms).","Company website read on 29 October 2026."],"hq":"Gothenburg","country":"SE","companyType":"devices","website":"https://navarisurgical.com/","stage":"startup","investors":[],"funding":[{"round":"Pre-seed","year":2022,"source":"https://navarisurgical.com/about/","note":"SEK 7.5 million, as stated on the company's about page."},{"round":"Grant","year":2025,"source":"https://navarisurgical.com/news/navari-is-granted-funding-from-vinnova/","note":"Vinnova grant under the call Acceleration of deeptech companies; amount not stated in the text read."}]},"route":"/companies/navari-surgical/","neighbours":{"section":[{"id":"devices","kind":"section","name":"Devices & Physical Therapies","route":"/fronts/devices/"},{"id":"surgery","kind":"section","name":"Surgery & Interventional","route":"/fronts/surgery/"}]}}